Rhodia will carry on reporting as funds deny consent
Solvay, the Belgian chemical company that bought high yield issuer Rhodia in September, has failed in its attempt to persuade investors to let it stop producing separate financial reports for Rhodia.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: